Significant association of hyperandrogenism and insulin resistance with the epigenetic alterations in PPARG1 gene in granulosa cells of PCOS females

Background Polycystic ovary syndrome (PCOS) is one of the most prevalent endocrine and metabolic disorders, affecting approximately 15% of females. This syndrome is characterized by its remarkable heterogeneity, and epigenetic factors may contribute to its development. Since the PPARG gene is crucia...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Egyptian Journal of Medical Human Genetics Ročník 26; číslo 1; s. 99 - 11
Hlavní autoři: Dashti, Zahra, Razban, Vahid, Fallahi, Jafar, Parsanezhad, Mohammad ebrahim, Mehdinejadiani, Shayesteh, Ghasemi, Nasrin
Médium: Journal Article
Jazyk:angličtina
Vydáno: Cairo Springer 01.12.2025
Springer Nature B.V
SpringerOpen
Témata:
ISSN:1110-8630, 2090-2441
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Abstract Background Polycystic ovary syndrome (PCOS) is one of the most prevalent endocrine and metabolic disorders, affecting approximately 15% of females. This syndrome is characterized by its remarkable heterogeneity, and epigenetic factors may contribute to its development. Since the PPARG gene is crucial for lipid and glucose metabolism, this study investigated the correlation between hyperinsulinemia, hyperandrogenism, and PPARG1 methylation in granulosa cells of polycystic ovary syndrome patients. Methods Follicular fluid was collected from 30 healthy control subjects, 25 patients with PCOS, and further subdivided into groups of 20 patients with PCOS exhibiting hyperandrogenism and insulin resistance, respectively. Granulosa cells were isolated from the follicular fluid. Subsequently, RNA and DNA were extracted, and bisulfite conversion was performed to analyze DNA methylation. The methylation status of the PPARG1 gene was assessed using MS-PCR, and qRT-PCR was employed to quantify PPARG1 mRNA expression. Results Analysis of the data revealed significant differences in PPARG1 gene methylation among the four patient groups. Notably, the PPARG1 gene promoter exhibited hypermethylation in both the PCOS-IR and PCOS-HA groups. This hypermethylation was associated with subsequent downregulation of PPARG1 gene expression compared to the control group (p < 0.05). Conclusion Our findings provide compelling evidence for the epigenetic regulation of PPARG1 in PCOS. PPARG1 promoter hypermethylation was observed specifically in PCOS patients with insulin resistance (IR) and hyperandrogenism (HA), suggesting a potential role for DNA methylation in the downregulation of PPARG1 expression in these subgroups. This link between PPARG1 methylation and gene expression required further investigation to elucidate its functional significance in the pathogenesis of PCOS.
AbstractList Background Polycystic ovary syndrome (PCOS) is one of the most prevalent endocrine and metabolic disorders, affecting approximately 15% of females. This syndrome is characterized by its remarkable heterogeneity, and epigenetic factors may contribute to its development. Since the PPARG gene is crucial for lipid and glucose metabolism, this study investigated the correlation between hyperinsulinemia, hyperandrogenism, and PPARG1 methylation in granulosa cells of polycystic ovary syndrome patients. Methods Follicular fluid was collected from 30 healthy control subjects, 25 patients with PCOS, and further subdivided into groups of 20 patients with PCOS exhibiting hyperandrogenism and insulin resistance, respectively. Granulosa cells were isolated from the follicular fluid. Subsequently, RNA and DNA were extracted, and bisulfite conversion was performed to analyze DNA methylation. The methylation status of the PPARG1 gene was assessed using MS-PCR, and qRT-PCR was employed to quantify PPARG1 mRNA expression. Results Analysis of the data revealed significant differences in PPARG1 gene methylation among the four patient groups. Notably, the PPARG1 gene promoter exhibited hypermethylation in both the PCOS-IR and PCOS-HA groups. This hypermethylation was associated with subsequent downregulation of PPARG1 gene expression compared to the control group (p < 0.05). Conclusion Our findings provide compelling evidence for the epigenetic regulation of PPARG1 in PCOS. PPARG1 promoter hypermethylation was observed specifically in PCOS patients with insulin resistance (IR) and hyperandrogenism (HA), suggesting a potential role for DNA methylation in the downregulation of PPARG1 expression in these subgroups. This link between PPARG1 methylation and gene expression required further investigation to elucidate its functional significance in the pathogenesis of PCOS.
Abstract Background Polycystic ovary syndrome (PCOS) is one of the most prevalent endocrine and metabolic disorders, affecting approximately 15% of females. This syndrome is characterized by its remarkable heterogeneity, and epigenetic factors may contribute to its development. Since the PPARG gene is crucial for lipid and glucose metabolism, this study investigated the correlation between hyperinsulinemia, hyperandrogenism, and PPARG1 methylation in granulosa cells of polycystic ovary syndrome patients. Methods Follicular fluid was collected from 30 healthy control subjects, 25 patients with PCOS, and further subdivided into groups of 20 patients with PCOS exhibiting hyperandrogenism and insulin resistance, respectively. Granulosa cells were isolated from the follicular fluid. Subsequently, RNA and DNA were extracted, and bisulfite conversion was performed to analyze DNA methylation. The methylation status of the PPARG1 gene was assessed using MS-PCR, and qRT-PCR was employed to quantify PPARG1 mRNA expression. Results Analysis of the data revealed significant differences in PPARG1 gene methylation among the four patient groups. Notably, the PPARG1 gene promoter exhibited hypermethylation in both the PCOS-IR and PCOS-HA groups. This hypermethylation was associated with subsequent downregulation of PPARG1 gene expression compared to the control group (p < 0.05). Conclusion Our findings provide compelling evidence for the epigenetic regulation of PPARG1 in PCOS. PPARG1 promoter hypermethylation was observed specifically in PCOS patients with insulin resistance (IR) and hyperandrogenism (HA), suggesting a potential role for DNA methylation in the downregulation of PPARG1 expression in these subgroups. This link between PPARG1 methylation and gene expression required further investigation to elucidate its functional significance in the pathogenesis of PCOS.
BackgroundPolycystic ovary syndrome (PCOS) is one of the most prevalent endocrine and metabolic disorders, affecting approximately 15% of females. This syndrome is characterized by its remarkable heterogeneity, and epigenetic factors may contribute to its development. Since the PPARG gene is crucial for lipid and glucose metabolism, this study investigated the correlation between hyperinsulinemia, hyperandrogenism, and PPARG1 methylation in granulosa cells of polycystic ovary syndrome patients.MethodsFollicular fluid was collected from 30 healthy control subjects, 25 patients with PCOS, and further subdivided into groups of 20 patients with PCOS exhibiting hyperandrogenism and insulin resistance, respectively. Granulosa cells were isolated from the follicular fluid. Subsequently, RNA and DNA were extracted, and bisulfite conversion was performed to analyze DNA methylation. The methylation status of the PPARG1 gene was assessed using MS-PCR, and qRT-PCR was employed to quantify PPARG1 mRNA expression.ResultsAnalysis of the data revealed significant differences in PPARG1 gene methylation among the four patient groups. Notably, the PPARG1 gene promoter exhibited hypermethylation in both the PCOS-IR and PCOS-HA groups. This hypermethylation was associated with subsequent downregulation of PPARG1 gene expression compared to the control group (p < 0.05).ConclusionOur findings provide compelling evidence for the epigenetic regulation of PPARG1 in PCOS. PPARG1 promoter hypermethylation was observed specifically in PCOS patients with insulin resistance (IR) and hyperandrogenism (HA), suggesting a potential role for DNA methylation in the downregulation of PPARG1 expression in these subgroups. This link between PPARG1 methylation and gene expression required further investigation to elucidate its functional significance in the pathogenesis of PCOS.
Polycystic ovary syndrome (PCOS) is one of the most prevalent endocrine and metabolic disorders, affecting approximately 15% of females. This syndrome is characterized by its remarkable heterogeneity, and epigenetic factors may contribute to its development. Since the PPARG gene is crucial for lipid and glucose metabolism, this study investigated the correlation between hyperinsulinemia, hyperandrogenism, and PPARG1 methylation in granulosa cells of polycystic ovary syndrome patients. Follicular fluid was collected from 30 healthy control subjects, 25 patients with PCOS, and further subdivided into groups of 20 patients with PCOS exhibiting hyperandrogenism and insulin resistance, respectively. Granulosa cells were isolated from the follicular fluid. Subsequently, RNA and DNA were extracted, and bisulfite conversion was performed to analyze DNA methylation. The methylation status of the PPARG1 gene was assessed using MS-PCR, and qRT-PCR was employed to quantify PPARG1 mRNA expression. Analysis of the data revealed significant differences in PPARG1 gene methylation among the four patient groups. Notably, the PPARG1 gene promoter exhibited hypermethylation in both the PCOS-IR and PCOS-HA groups. This hypermethylation was associated with subsequent downregulation of PPARG1 gene expression compared to the control group (p < 0.05). Our findings provide compelling evidence for the epigenetic regulation of PPARG1 in PCOS. PPARG1 promoter hypermethylation was observed specifically in PCOS patients with insulin resistance (IR) and hyperandrogenism (HA), suggesting a potential role for DNA methylation in the downregulation of PPARG1 expression in these subgroups. This link between PPARG1 methylation and gene expression required further investigation to elucidate its functional significance in the pathogenesis of PCOS.
Audience Professional
Academic
Author Razban, Vahid
Dashti, Zahra
Parsanezhad, Mohammad ebrahim
Ghasemi, Nasrin
Fallahi, Jafar
Mehdinejadiani, Shayesteh
Author_xml – sequence: 1
  fullname: Dashti, Zahra
– sequence: 2
  fullname: Razban, Vahid
– sequence: 3
  fullname: Fallahi, Jafar
– sequence: 4
  fullname: Parsanezhad, Mohammad ebrahim
– sequence: 5
  fullname: Mehdinejadiani, Shayesteh
– sequence: 6
  fullname: Ghasemi, Nasrin
BookMark eNptkcFq3DAQhk1JoZu0L9CToGenM5IsW8dladNAIEvTno0sj7xabGlreSl5jzxw5SaQHsocpBn9_zca5rK4CDFQUXxEuEZs1OckBUheAq9KgFpgqd4UGw4aSi4lXhQbRISyUQLeFZcpHQFUJWq5KZ4e_BC889aEhZmUovVm8TGw6Njh8USzCf0cBwo-TSzfmQ_pPPrAZko-LSZYYr_9cmDLgRidfFbS4i0z45K9KyllC9vvt99vkK2vazpk7HmMyTBL45jWZvvd_QNzNJmR0vvirTNjog8v51Xx8-uXH7tv5d39ze1ue1daoaQqHeoGrQKOTU3caOkkACqtyGhNwjnsDHYEvHeguas67pQVdU2u76zWKK6K22duH82xPc1-MvNjG41v_xbiPLRmztOM1Jq6IsC-7wx0UrpKZ6RAjVxJ02Ozsj49s05z_HWmtLTHeJ5D_n4rOCoFoJV8VQ15ztYHF5fZ2Mkn224bKRC4Bp5V1_9R5ehp8jZv3vlc_8fwB37boA0
ContentType Journal Article
Copyright COPYRIGHT 2025 Springer
Copyright Springer Nature B.V. Dec 2025
Copyright_xml – notice: COPYRIGHT 2025 Springer
– notice: Copyright Springer Nature B.V. Dec 2025
DBID 3V.
7X7
7XB
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
CWDGH
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M7P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
DOA
DOI 10.1186/s43042-025-00731-6
DatabaseName ProQuest Central (Corporate)
ProQuest Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
ProQuest SciTech Collection
ProQuest Natural Science Collection
ProQuest Hospital Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials - QC
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One Community College
Middle East & Africa Database
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
ProQuest Health & Medical Collection
Biological Science Database
ProQuest Central Premium
ProQuest One Academic
ProQuest Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic (retired)
ProQuest One Academic UKI Edition
ProQuest Central China
DOAJ Directory of Open Access Journals
DatabaseTitle Publicly Available Content Database
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Central China
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Middle East & Africa Database
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Biological Science Collection
ProQuest Central (New)
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
DatabaseTitleList

Publicly Available Content Database

Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: PIMPY
  name: ProQuest Publicly Available Content Database
  url: http://search.proquest.com/publiccontent
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2090-2441
EndPage 11
ExternalDocumentID oai_doaj_org_article_a75e01ddba0b44f59f093191264ad181
A843102902
GeographicLocations Iran
GeographicLocations_xml – name: Iran
GroupedDBID ---
-OY
0R~
4.4
457
4JU
53G
5VS
7X7
8FI
8FJ
8R4
8R5
AAEDT
AAFWJ
AAIKJ
AAKKN
ABDBF
ABEEZ
ABMAC
ABUWG
ACACY
ACGFS
ACIHN
ACPRK
ACUHS
ACULB
ADBBV
ADEZE
AEAQA
AFFHD
AFGXO
AFKRA
AFPKN
AFWDF
AGHFR
AHMBA
AKRWK
ALMA_UNASSIGNED_HOLDINGS
AMTXH
BAPOH
BAWUL
BBNVY
BCNDV
BENPR
BHPHI
BPHCQ
C24
C6C
CCPQU
CWDGH
DIK
EBD
EBS
EOJEC
ESX
FDB
FYUFA
GROUPED_DOAJ
GX1
HCIFZ
HMCUK
IAO
IGS
IHR
INH
ITC
IXB
KQ8
KWQ
M7P
O-L
O9-
OBODZ
OK1
PEKGL
PHGZM
PHGZT
PIMPY
PQGLB
Q2X
SEL
SES
SOJ
TUS
UKHRP
XH2
~8M
3V.
7XB
8FE
8FH
8FK
AZQEC
DWQXO
GNUQQ
K9.
LK8
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
ID FETCH-LOGICAL-c3646-f1981c602187e2a94f4001696ea99e3ff1ba1be02df092f5b2f6c377efdbc9913
IEDL.DBID DOA
ISSN 1110-8630
IngestDate Fri Oct 03 12:52:00 EDT 2025
Sat Oct 18 23:47:07 EDT 2025
Tue Nov 11 10:49:12 EST 2025
Tue Nov 04 18:10:54 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3646-f1981c602187e2a94f4001696ea99e3ff1ba1be02df092f5b2f6c377efdbc9913
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
OpenAccessLink https://doaj.org/article/a75e01ddba0b44f59f093191264ad181
PQID 3216600964
PQPubID 54962
PageCount 11
ParticipantIDs doaj_primary_oai_doaj_org_article_a75e01ddba0b44f59f093191264ad181
proquest_journals_3216600964
gale_infotracmisc_A843102902
gale_infotracacademiconefile_A843102902
PublicationCentury 2000
PublicationDate 2025-12-01
PublicationDateYYYYMMDD 2025-12-01
PublicationDate_xml – month: 12
  year: 2025
  text: 2025-12-01
  day: 01
PublicationDecade 2020
PublicationPlace Cairo
PublicationPlace_xml – name: Cairo
PublicationTitle Egyptian Journal of Medical Human Genetics
PublicationYear 2025
Publisher Springer
Springer Nature B.V
SpringerOpen
Publisher_xml – name: Springer
– name: Springer Nature B.V
– name: SpringerOpen
SSID ssj0065374
Score 2.329069
Snippet Background Polycystic ovary syndrome (PCOS) is one of the most prevalent endocrine and metabolic disorders, affecting approximately 15% of females. This...
Polycystic ovary syndrome (PCOS) is one of the most prevalent endocrine and metabolic disorders, affecting approximately 15% of females. This syndrome is...
BackgroundPolycystic ovary syndrome (PCOS) is one of the most prevalent endocrine and metabolic disorders, affecting approximately 15% of females. This...
Abstract Background Polycystic ovary syndrome (PCOS) is one of the most prevalent endocrine and metabolic disorders, affecting approximately 15% of females....
SourceID doaj
proquest
gale
SourceType Open Website
Aggregation Database
StartPage 99
SubjectTerms Androgens
Bisulfite
Body fat
Development and progression
Dextrose
Diabetes
DNA methylation
Down-regulation
Epigenetic inheritance
Epigenetics
Females
Follicular fluid
Gene expression
Genes
Glucose
Glucose metabolism
Granulosa cells
Hyperandrogenism
Hyperinsulinemia
Infertility
Insulin resistance
Lipid metabolism
Lipids
Menstruation
Metabolic disorders
Metabolic syndrome
Methylation
Obesity
Ovaries
Ovulation
PCO
Polycystic ovary syndrome
Polymerase chain reaction
PPARG1
Stein-Leventhal syndrome
Testosterone
Thermal cycling
Type 2 diabetes
Ultrasonic imaging
SummonAdditionalLinks – databaseName: ProQuest Central
  dbid: BENPR
  link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELZgi1AvlKfYtiAfkDhZjR3HiU_VtmrhAEvUAuot8nNZiW62yZZfwg9mJuuo6gEu3JI4iS3Pw59nxjOEvLNYdNHrjLkYDJNRGGa9N8xoC4sZl04M57i_fyrn8-rqStfJ4NansMpRJw6K2rcObeRHueBKIeCWx-sbhlWj0LuaSmg8JDuYqUxOyM7J2by-GHWxKvIhDzMIdMYqlWfjsZlKHfUSd_IMy7miu4qzMW3_35TzsOKc7_3vWJ-SJwlr0tmWOZ6RB2H1nDz-nLzpL8jvy-VihaFCMLvU3NGJtpH-gP0pLGO-a4HDlv01hWuaAtcpbNERdgK_ULTjUgCRNKwxryceiaSDB35rCYRPaF3PLj5wiq14u4Df3v5se0PRadBjZ_Xpl0sawzXMR_-SfDs_-3r6kaUqDczlSioWua64U4gVyiCMllEijtQqGK1DHiO3htuQCR8zLWJhRVQuL8sQvXWATvNXZLJqV-E1oQAvQwyF95UvgEsAq1QO6BMKHWLluZ2SEyRQs94m4mgwNfbwoO0WTZK0xpRFyLj31mRWylho6Bb0DAfkZzzgmSl5j-RtUIA3nXEmnUOAIWAqrGZWAabKhM7ElBzeexMEz91vHqnfJMHvmzvS7_-7-YDsCuS9ITLmkEw23W14Qx65X5tl371NfPwHFeH8wA
  priority: 102
  providerName: ProQuest
Title Significant association of hyperandrogenism and insulin resistance with the epigenetic alterations in PPARG1 gene in granulosa cells of PCOS females
URI https://www.proquest.com/docview/3216600964
https://doaj.org/article/a75e01ddba0b44f59f093191264ad181
Volume 26
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 2090-2441
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0065374
  issn: 1110-8630
  databaseCode: DOA
  dateStart: 20100101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVPQU
  databaseName: Biological Science Database
  customDbUrl:
  eissn: 2090-2441
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0065374
  issn: 1110-8630
  databaseCode: M7P
  dateStart: 20200101
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/biologicalscijournals
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Health & Medical Collection
  customDbUrl:
  eissn: 2090-2441
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0065374
  issn: 1110-8630
  databaseCode: 7X7
  dateStart: 20200101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Middle East & Africa Database
  customDbUrl:
  eissn: 2090-2441
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0065374
  issn: 1110-8630
  databaseCode: CWDGH
  dateStart: 20200101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/middleeastafrica
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl:
  eissn: 2090-2441
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0065374
  issn: 1110-8630
  databaseCode: BENPR
  dateStart: 20200101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Publicly Available Content Database
  customDbUrl:
  eissn: 2090-2441
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0065374
  issn: 1110-8630
  databaseCode: PIMPY
  dateStart: 20200101
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/publiccontent
  providerName: ProQuest
– providerCode: PRVAVX
  databaseName: SpringerLink Open Access Journals
  customDbUrl:
  eissn: 2090-2441
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0065374
  issn: 1110-8630
  databaseCode: C24
  dateStart: 20191201
  isFulltext: true
  titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22
  providerName: Springer Nature
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LTxsxELbalEMvCNQiwiPyAakni7XX-_AxoPCQIKyStgqnlZ8QCZIom_BL-MHM7G7UckC99La73oc9n73zjT0zJuTE4KaLTkXMBq-ZDEIz45xmWhlQZlxaUcdx_77JhsN8MlHFX1t9oU9Ykx64EdypzhIfceeMjoyUIVEBbHAwMkCRa8froGsBrKcxpjZRMXl6Wkk01Bnu1oqrUZxtsvJ_9O-tFcrFDtlumSDtNzXYJZ_87Bt5HU8fZui9Aw2m-o_o6DzQRzAZQbO45RxAn1bPFI5p60tOwWpGJggQUpxapcDrqF9gqk2MUqT1ongzOQeP0KLojy45xVI8fYDXrp_mlaY4j1_hx4rzuzEN_hnaUH0nvy4GP8-vWLtxArNxKlMWuMq5TVF9Z15oJYNEaqdSr5XycQjcaG58JBwIU4TEiJDaOMt8cMYCYYz3SGc2n_l9QoHx-eAT53KXAHBAH3ILMvWJ8iF33HTJGQq1XDS5MUrMVl1fAAzLFsPyXxh2yQ-EpMQxtVpqq9vQAKgCZqcq-znQnEioSHTJ0bs7YSzY98UbUMt2LFZlLHiaoqkmD_5HZQ_JV4G9qnZpOSKd1XLtj8mWfVlNq2WPfM4mWY98ORsMi1Gv7pQ99Cct4FpxfVvcvwEko-pa
linkProvider Directory of Open Access Journals
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Nb9MwGLbGQLAL32hlA3wAcbIWO4kTH9BUBmPTulKxgXrL_FkqbU2XdCD-B7-D38j7pgnTDnDbgVsat3HkPn7ex_b7QchLg0UXnYqYDV6zJAjNjHOaaWXAmPHEiiaO-8sgGw7z8ViNVsivLhYG3So7TmyI2pUW98i3YsGlRMGdbM_PGVaNwtPVroTGEhYH_sd3WLLVb_bfwf_7Sojd98c7e6ytKsBsLBPJAiyzuZVo2zIvtEpCgrpHSa-V8nEI3GhufCRciJQIqRFB2jjLfHDGgpqK4bk3yE3g8QxdyLLxnwWeTOMm6zPQR8RyGUddkE4ut-oE9w0YFo_FwzHOuiIBfzMFjX3bvfe_jcx9crdV0rS_hP4DsuJnD8ntw9ZX4BH5eTSdzNARCrBD9SUKaRnoV1h9g5F2VQnzZ1qfUbimrVs-rXyNohpmA8VdagoSmfo5Zi3FgE_a-Bcs9znhJ3Q06n_6wCm24scJPPbitKw1xSORGjsb7Xw8osGfwfjXj8nnaxmTJ2R1Vs78OqEgnn3wqXO5S2EOgBLLLeDBp8qH3HHTI28REMV8mWakwMTfzY2ymhQtjxQ6S33EnTM6MkkSUgXdAoty0LXagVrrkdcIpwLpaVFpq9soC3gFTPRV9HNQjJFQkeiRzSvfBFqxV5s7tBUtrdXFJdSe_rv5Bbmzd3w4KAb7w4MNsiYQ940P0CZZXVQX_hm5Zb8tpnX1vJlBlJxcNzB_A5p9WAM
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwELZKiyouvBELBXwAcbI2dhInPiC0fSxULUvUAuot-LmsRDdLsgXxP_pr-uuYySaqeoBbD9ySOHGi-JuZz_Y8CHlpsOiiUxGzwWuWBKGZcU4zrQwYM55Y0cZxfznMJpP85EQVa-Sij4VBt8peJ7aK2lUW18iHseBSIuFOhqFziyh2x28XPxhWkMKd1r6cxgoiB_73L5i-NW_2d2GsXwkx3vu08551FQaYjWUiWYApN7cS7VzmhVZJSJADKem1Uj4OgRvNjY-EC5ESITUiSBtnmQ_OWGBWMfR7g2xkQDJAuja29ybFUW8HZBq3OaBBmUQsl3HUh-zkctgkuIrAsJQsbpVx1pcM-JthaK3d-M7__J_uktsdx6ajlVDcI2t-fp9sfui8CB6Q8-PZdI4uUoAqqi_xSatAv8G8HMy3qyuQrFlzSuGYdg77tPYN0m2QE4rr1xTIM_ULzGeKoaC09TxYrYDCI7QoRkfvOMVWPJ1Ct2ffq0ZT3Cxp8GXFzsdjGvwpjEXzkHy-ln_yiKzPq7l_TCjQah986lzuUpAO4Gi5BWz4VPmQO24GZBvBUS5WCUhKTAneXqjqadlpmFJnqY-4c0ZHJklCquC1oF85MF7tgMcNyGuEVomKa1lrq7v4C_gETAFWjnLgkpFQkRiQrSt3gsKxV5t75JWdwmvKS9g9-XfzC7IJeCwP9ycHT8ktgSLQOgdtkfVlfeafkZv253LW1M87caLk63Uj8w8JZmIk
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Significant+association+of+hyperandrogenism+and+insulin+resistance+with+the+epigenetic+alterations+in+PPARG1+gene+in+granulosa+cells+of+PCOS+females&rft.jtitle=Egyptian+Journal+of+Medical+Human+Genetics&rft.au=Zahra+Dashti&rft.au=Vahid+Razban&rft.au=Jafar+Fallahi&rft.au=Mohammad+ebrahim+Parsanezhad&rft.date=2025-12-01&rft.pub=SpringerOpen&rft.eissn=2090-2441&rft.volume=26&rft.issue=1&rft.spage=1&rft.epage=11&rft_id=info:doi/10.1186%2Fs43042-025-00731-6&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_a75e01ddba0b44f59f093191264ad181
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1110-8630&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1110-8630&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1110-8630&client=summon